CSCR
MCID: CNT060
MIFTS: 41

Central Serous Chorioretinopathy (CSCR) malady

Categories: Rare diseases, Eye diseases, Bone diseases, Immune diseases

Aliases & Classifications for Central Serous Chorioretinopathy

Aliases & Descriptions for Central Serous Chorioretinopathy:

Name: Central Serous Chorioretinopathy 50 56 69
Central Serous Chorioretinopathy After Bone Marrow Transplantation 50
Central Serous Choroidopathy 50
Cscr 56

Characteristics:

Orphanet epidemiological data:

56
central serous chorioretinopathy
Inheritance: Not applicable;

Classifications:

Orphanet: 56  
Rare eye diseases


External Ids:

Orphanet 56 ORPHA443079
ICD10 via Orphanet 34 H35.7

Summaries for Central Serous Chorioretinopathy

NIH Rare Diseases : 50 central serous chorioretinopathy is a disease that causes fluid to build up under the retina, the back part of the inner eye that sends sight information to the brain. the fluid leaks from the choroid (the blood vessel layer under the retina). the cause of this condition is unknown but stress can be a risk factor. signs and symptoms include dim and blurred blind spot in the center of vision, distortion of straight lines and seeing objects as smaller or farther away. many cases of central serous chorioretinopathy improve without treatment after 1-2 months. laser treatment may be an option for other individuals. last updated: 1/30/2014

MalaCards based summary : Central Serous Chorioretinopathy, also known as central serous chorioretinopathy after bone marrow transplantation, is related to choroiditis and retinitis, and has symptoms including localized edema An important gene associated with Central Serous Chorioretinopathy is CFH (Complement Factor H), and among its related pathways/superpathways are Fluid shear stress and atherosclerosis and Apelin signaling pathway. The drugs Eplerenone and Spironolactone have been mentioned in the context of this disorder. Affiliated tissues include eye, retina and bone.

Related Diseases for Central Serous Chorioretinopathy

Diseases related to Central Serous Chorioretinopathy via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 76)
id Related Disease Score Top Affiliating Genes
1 choroiditis 10.8
2 retinitis 10.7
3 retinal detachment 10.4
4 endotheliitis 10.2
5 obstructive sleep apnea 10.2
6 sleep apnea 10.2
7 central congenital hypothyroidism 10.2 CFH SERPINE1
8 thyroid cancer, anaplastic 10.1 CFH SERPINE1
9 multiple vertebral anomalies unusual facies 10.1 ARMS2 CFH
10 hand, foot and mouth disease 10.1 ARMS2 CFH
11 endosalpingiosis 10.1 ARMS2 CFH
12 rhizomelic chondrodysplasia punctata 10.1 ARMS2 CFH
13 cone-rod dystrophy 17 10.1 ARMS2 CFH
14 vogt-koyanagi-harada disease 10.1
15 placental choriocarcinoma 10.0 ARMS2 CFH
16 inflammatory bowel disease 11 10.0 PLAT SERPINE1
17 brazilian hemorrhagic fever 10.0 PLAT SERPINE1
18 chronic fatigue syndrome 10.0 PLAT SERPINE1
19 secretory diarrhea myopathy and deafness 10.0 PLAT SERPINE1
20 acute proliferative glomerulonephritis 10.0 CFH SERPINE1
21 sezary's disease 10.0 PLAT SERPINE1
22 lynch syndrome 10.0 PLAT SERPINE1
23 monocular exotropia 10.0 PLAT SERPINE1
24 perrault syndrome 10.0 PLAT SERPINE1
25 retinal degeneration 10.0
26 neuropathy 10.0
27 retinitis pigmentosa 10.0
28 uveitis 10.0
29 psoriasis 10.0
30 zika virus congenital syndrome 10.0 PLAT SERPINE1
31 xerophthalmia 10.0 PLAT SERPINE1
32 pregnancy loss, recurrent 1 9.9 PLAT SERPINE1
33 brill-zinsser disease 9.9 PLAT SERPINE1
34 immunodeficiency, common variable, 6 9.9 PLAT SERPINE1
35 leukocyte disease 9.9 PLAT SERPINE1
36 congenital chloride diarrhea 9.9 PLAT SERPINE1
37 bone development disease 9.9 PLAT SERPINE1
38 adult t-cell leukemia 9.9 PLAT SERPINE1
39 hallermann-streiff syndrome 9.9
40 ischemia 9.8
41 punctate inner choroidopathy 9.8
42 arteritic anterior ischemic optic neuropathy 9.8
43 susac syndrome 9.8
44 lymphoma 9.8
45 hyperaldosteronism 9.8
46 systemic lupus erythematosus 9.8
47 alexithymia 9.8
48 rhinitis 9.8
49 hodgkin lymphoma 9.8
50 colitis 9.8

Graphical network of the top 20 diseases related to Central Serous Chorioretinopathy:



Diseases related to Central Serous Chorioretinopathy

Symptoms & Phenotypes for Central Serous Chorioretinopathy

UMLS symptoms related to Central Serous Chorioretinopathy:


localized edema

Drugs & Therapeutics for Central Serous Chorioretinopathy

Drugs for Central Serous Chorioretinopathy (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 103)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Eplerenone Approved Phase 4,Phase 2,Phase 3 107724-20-9 150310 443872
2
Spironolactone Approved Phase 4,Phase 2,Phase 3 1952-01-7, 52-01-7 5833
3
Verteporfin Approved, Investigational Phase 4,Phase 1,Phase 2 129497-78-5
4
Ranibizumab Approved Phase 4,Phase 1,Phase 2 347396-82-1 459903
5 diuretics Phase 4,Phase 2,Phase 3
6 Diuretics, Potassium Sparing Phase 4,Phase 2,Phase 3
7 Hormone Antagonists Phase 4,Phase 2,Phase 3,Phase 1
8 Hormones Phase 4,Phase 2,Phase 3,Phase 1
9 Hormones, Hormone Substitutes, and Hormone Antagonists Phase 4,Phase 2,Phase 3,Phase 1
10 Mineralocorticoid Receptor Antagonists Phase 4,Phase 2,Phase 3
11 Mineralocorticoids Phase 4,Phase 2,Phase 3
12 Natriuretic Agents Phase 4,Phase 2,Phase 3
13 Dermatologic Agents Phase 4,Phase 2,Phase 1
14 Angiogenesis Inhibitors Phase 4,Phase 2,Phase 3,Phase 1
15 Angiogenesis Modulating Agents Phase 4,Phase 2,Phase 3,Phase 1
16 Photosensitizing Agents Phase 4,Phase 1,Phase 2
17
Bevacizumab Approved, Investigational Phase 2, Phase 3 216974-75-3
18
Methotrexate Approved Phase 2 1959-05-2, 59-05-2 126941
19
Hydrocortisone Approved, Vet_approved Phase 1, Phase 2 50-23-7 5754 657311
20
Copper Approved Phase 2 15158-11-9, 7440-50-8 27099
21
Selenium Approved, Vet_approved Phase 2 7782-49-2
22
Zinc Approved Phase 2 7440-66-6 32051 23994
23
Amoxicillin Approved, Vet_approved Phase 1, Phase 2 26787-78-0 33613 2171
24
Metronidazole Approved Phase 1, Phase 2 443-48-1 4173
25
Omeprazole Approved, Investigational, Vet_approved Phase 1, Phase 2 73590-58-6 4594
26
Ketoconazole Approved, Investigational Phase 2 65277-42-1 47576 3823
27
Miconazole Approved, Investigational, Vet_approved Phase 2 22916-47-8 4189
28
Finasteride Approved Phase 1, Phase 2 98319-26-7 57363
29
Mifepristone Approved, Investigational Phase 2 84371-65-3 55245
30
Folic Acid Approved, Nutraceutical, Vet_approved Phase 2 59-30-3 6037
31
leucovorin Approved, Nutraceutical Phase 2 58-05-9 54575, 6560146 143
32
Lutein Approved, Nutraceutical Phase 2 127-40-2 6433159 5368396
33
Manganese Approved, Nutraceutical Phase 2 7439-96-5 27854
34
Riboflavin Approved, Nutraceutical, Vet_approved Phase 2 83-88-5 493570
35
Vitamin A Approved, Nutraceutical, Vet_approved Phase 2 11103-57-4, 68-26-8 445354
36
Vitamin C Approved, Nutraceutical Phase 2 50-81-7 5785 54670067
37
Vitamin E Approved, Nutraceutical, Vet_approved Phase 2 59-02-9 14985
38 Antimetabolites Phase 2
39 Antimetabolites, Antineoplastic Phase 2
40 Antirheumatic Agents Phase 2
41 Folic Acid Antagonists Phase 2
42 Immunosuppressive Agents Phase 2
43 Nucleic Acid Synthesis Inhibitors Phase 2
44 Vitamin B Complex Phase 2
45 Anecortave Phase 1, Phase 2
46 Anti-Inflammatory Agents Phase 1, Phase 2
47 Cortisol succinate Phase 1, Phase 2
48 Hydrocortisone 17-butyrate 21-propionate Phase 1, Phase 2
49 Hydrocortisone acetate Phase 1, Phase 2
50 Antioxidants Phase 2

Interventional clinical trials:

(show top 50) (show all 56)
id Name Status NCT ID Phase
1 Eplerenone Treatment for Chronic Central Serous Chorioretinopathy in Hungarian Population Completed NCT02462499 Phase 4
2 Study of Photodynamic Therapy (PDT) in Patients With Central Serous Chorioretinopathy (CSC) Completed NCT01574430 Phase 4
3 Prospective Randomized Controlled Treatment Trial for Chronic Central Serous Chorioretinopathy Recruiting NCT01797861 Phase 4
4 Photodynamic Therapy Versus Eplerenone: Treatment Trial for Chronic Central Serous Chorioretinopathy Recruiting NCT03079141 Phase 4
5 Micropulse 577nm Laser vs Traditional Laser Treatment in Central Serous Chorioretinopathy Recruiting NCT02735213 Phase 4
6 Cohort Study of the Clinical Course of Macular Diseases in Kagawa Recruiting NCT02321267 Phase 4
7 PRedictive Factors and Changes From Treatment in Idiopathic Polypoidal Choroidal Vasuclopathy Versus Central Serous Chorioretinopathy Versus Neovascular Age Related Macular Degeneration With afLibercept Not yet recruiting NCT02681783 Phase 4
8 Intravitreal Bevacizumab for the Treatment of Central Serous Chorioretinopathy Unknown status NCT00418431 Phase 2, Phase 3
9 A Study of the Beneficial Effects of Eplerenone on Central Serous Chorioretinopathy Not yet recruiting NCT02215330 Phase 2, Phase 3
10 Methotrexate for Central Serous Chorioretinopathy Treatment Trial Unknown status NCT01633983 Phase 2
11 Eplerenone For the Treatment of Chronic Central Serous Chorioretinopathy Unknown status NCT02153125 Phase 2
12 Treatment of Chronic Central Serous Chorioretinopathy With Open-Label Anecortave Acetate Completed NCT00489840 Phase 1, Phase 2
13 High-dose Antioxidants for Central Serous Chorioretinopathy Completed NCT00963131 Phase 2
14 Effect of Helicobacter Pylori Treatment on Idiopathic Central Serous Chorioretinopathy (ICSCR) Completed NCT00817245 Phase 1, Phase 2
15 The Safety & Efficacy of Intravitreal Aflibercept Injection in Patients With Persistent Central Serous Chorioretinopathy Completed NCT01710332 Phase 2
16 A Pilot Study of the Treatment of Central Serous Chorioretinopathy With Ketoconazole Completed NCT00211393 Phase 2
17 Efficacy and Safety of Intravitreal Aflibercept Injection for Subacute Central Serous Chorioretinopathy Completed NCT01971190 Phase 2
18 Ranibizumab Versus Low-fluence Photodynamic Therapy in the Treatment of Chronic Central Serous Chorioretinopathy Completed NCT01325181 Phase 1, Phase 2
19 Selective Retina Therapy (SRT) in Patients With Idiopathic Central Serous Retinopathy Completed NCT00987077 Phase 2
20 Extension Study for the Evaluation of Finasteride in the Treatment of Chronic Central Serous Chorioretinopathy Completed NCT01227993 Phase 1, Phase 2
21 Pilot Study for the Evaluation of Finasteride in the Treatment of Chronic Central Serous Chorioretinopathy Completed NCT00837252 Phase 1, Phase 2
22 Photodynamic Therapy Using Verteporfin for Treatment of Chronic Central Serous Chorioretinopathy (CSC) Completed NCT00211445 Phase 2
23 Topical Interferon Gamma-1b for Central Serous Chorioretinopathy Completed NCT01468337 Phase 1, Phase 2
24 Short-Term Oral Mifepristone for Central Serous Chorioretinopathy Recruiting NCT02354170 Phase 2
25 Eplerenone for Central Serous Chorioretinopathy Recruiting NCT01822561 Phase 2
26 Endpoint Management Software for Photothermal Stimulation of Macular Diseases Recruiting NCT01975103 Phase 2
27 Finasteride for Chronic Central Serous Chorioretinopathy Terminated NCT01585441 Phase 2
28 Intravitreal Ranibizumab Treatment of Central Serous Chorioretinopathy Completed NCT00403325 Phase 1
29 Eye Patch Therapy for Central Serous Retinopathy (CSR) Completed NCT02036632 Phase 1
30 The Safe Effective Light Dose of Photodynamic Therapy for Chronic Central Serous Chorioretinopathy Unknown status NCT01630863
31 The Effect of Therapy With Bevacizumab in Chronic Central Serous Chorioretinopathy Unknown status NCT00864773
32 Study on the Use of Micropulse Laser to Treat Central Serous Chorioretinopathy Unknown status NCT01982383
33 Selective RPE Laser Treatment (SRT) for Various Macular Diseases Unknown status NCT00403884
34 OCT in Rare Chorioretinal Diseases Unknown status NCT02141308
35 Central Serous Chorioretinopathy Treated by Modified Photodynamic Therapy Completed NCT01019668
36 Comparison of Multifocal Electroretinogram Assessment in Chronic Central Serous Chorioretinopathy (CSC) Between Laser Treatment Group and Photodynamic Therapy Group in Chronic Central Serous Chorioretinopathy Completed NCT00803517
37 Micropulse Diode Laser Treatment for Chronic Central Serous Chorioretinopathy Completed NCT01327170
38 Central Serous Chorioretinopathy: Etiology, Course and Prognosis Completed NCT01378130
39 Eplerenone for the Treatment of Central Serous Chorioretinopathy Completed NCT01990677
40 Bevacizumab Versus Micropulse in Central Serous Chorioretinopathy (CSC) Completed NCT00802906
41 Persona of Central Serous Chorioretinopathy Completed NCT02819622
42 Microperimetric Evaluation After Half-dose Photodynamic Therapy for Chronic Central Serous Chorioretinopathy Completed NCT01434095
43 Genetic Analysis of Chronic Central Serous Chorioretinopathy Masquerading as Neovascular AMD Completed NCT01880788
44 Choroidal Thickness Measurements During Central Serous Chorioretinopathy (CSCR) Treatment Completed NCT01610804
45 Evaluation and Treatment of Patients With Retinal Disease Completed NCT00005784
46 Evaluation of the Precision of the Microperimetry Function of the Spectral OCT/SLO Completed NCT01692938
47 Multimodal Imaging in Central Serous Chorioretinopathy Recruiting NCT02889185
48 Angiographic Characteristics of CSC, PCV Patients and Thrombotic Bio-markers Recruiting NCT02815176
49 Selective Retinal Pigment Epithelium Laser Therapy for Macular Disease of the Retina Recruiting NCT02088151
50 Cohort Study of the Clinical Course of Macular Diseases in Japanese Recruiting NCT02081339

Search NIH Clinical Center for Central Serous Chorioretinopathy

Genetic Tests for Central Serous Chorioretinopathy

Anatomical Context for Central Serous Chorioretinopathy

MalaCards organs/tissues related to Central Serous Chorioretinopathy:

39
Eye, Retina, Bone, Bone Marrow, Brain, Endothelial, Adrenal Cortex

Publications for Central Serous Chorioretinopathy

Articles related to Central Serous Chorioretinopathy:

(show top 50) (show all 623)
id Title Authors Year
1
Subfoveal Choroidal Thickness in Central Serous Chorioretinopathy: A Meta-Analysis. ( 28076442 )
2017
2
Systemic Mineralocorticoid Antagonists in the Treatment of Central Serous Chorioretinopathy. ( 27929707 )
2017
3
CYSTOID MACULAR EDEMA AND CYSTOID MACULAR DEGENERATION AS A RESULT OF MULTIPLE PATHOGENIC FACTORS IN THE SETTING OF CENTRAL SEROUS CHORIORETINOPATHY. ( 27902539 )
2017
4
Increased Choroidal Vascularity in Central Serous Chorioretinopathy Quantified Using Swept-Source Optical Coherence Tomography. ( 27894511 )
2017
5
High-Resolution Imaging of Intraretinal Structures in Active and Resolved Central Serous Chorioretinopathy. ( 28055101 )
2017
6
Distinguishing features of acute Vogt-Koyanagi-Harada disease and acute central serous chorioretinopathy on optical coherence tomography angiography and en face optical coherence tomography imaging. ( 28091938 )
2017
7
Acute lupus choroidopathy: multimodal imaging and differential diagnosis from central serous chorioretinopathy. ( 28050729 )
2017
8
ACUTE CENTRAL SEROUS CHORIORETINOPATHY: Factors Influencing Episode Duration. ( 28067724 )
2017
9
Chronic central serous chorioretinopathy: long-term follow-up and vision-related quality of life. ( 28053499 )
2017
10
Retinal sensitivity after selective retina therapy (SRT) on patients with central serous chorioretinopathy. ( 27497611 )
2016
11
Fighter Pilot with Recurrent Central Serous Chorioretinopathy. ( 27662355 )
2016
12
The time of resolution and the rate of recurrence in acute central serous chorioretinopathy following spontaneous resolution and low-fluence photodynamic therapy: a case-control study. ( 27101755 )
2016
13
Subfoveal choroidal thickness changes after intravitreal bevacizumab therapy for central serous chorioretinopathy. ( 27982209 )
2016
14
Changes in Choroidal Structures in Eyes with Chronic Central Serous Chorioretinopathy after Half-Dose Photodynamic Therapy. ( 27636093 )
2016
15
Central serous chorioretinopathy following medial transposition of split lateral rectus muscle for complete oculomotor nerve palsy. ( 28017901 )
2016
16
Evaluation and correlation of stress scores with blood pressure, endogenous cortisol levels, and homocysteine levels in patients with central serous chorioretinopathy and comparison with age-matched controls. ( 27958201 )
2016
17
Bullous Variant of Central Serous Chorioretinopathy: Expansion of Phenotypic Features Using Multimethod Imaging. ( 27084564 )
2016
18
Choroidal thickness evaluation of healthy eyes, central serous chorioretinopathy, and fellow eyes using spectral domain optical coherence tomography in Indian population. ( 27905337 )
2016
19
LOW-INTENSITY/HIGH-DENSITY SUBTHRESHOLD DIODE MICROPULSE LASER FOR CENTRAL SEROUS CHORIORETINOPATHY. ( 27206160 )
2016
20
Chronic central serous chorioretinopathy as a presenting symptom of Cushing syndrome. ( 27135093 )
2016
21
Relationship between mean platelet volume and central serous chorioretinopathy. ( 27113057 )
2016
22
Central serous chorioretinopathy secondary to epidural corticosteroid infiltration. ( 27532541 )
2016
23
Half-Dose versus Half-Time Photodynamic Therapy for Central Serous Chorioretinopathy. ( 27084002 )
2016
24
Scleral resection in chronic central serous chorioretinopathy complicated by exudative retinal detachment. ( 27617266 )
2016
25
ANTIANGIOGENICS IN CHOROIDAL NEOVASCULARIZATION ASSOCIATED WITH LASER IN CENTRAL SEROUS CHORIORETINOPATHY. ( 27115855 )
2016
26
OCT Angiography Findings in Acute Central Serous Chorioretinopathy. ( 27065370 )
2016
27
Detection of Choroidal Neovascularization in Central Serous Chorioretinopathy Using Optical Coherence Tomographic Angiography. ( 27562525 )
2016
28
Half-dose photodynamic therapy for chronic central serous chorioretinopathy: Efficacy and safety outcomes in real world. ( 27126174 )
2016
29
Is the unaffected eye really unaffected? Color Doppler ultrasound findings in unilaterally active central serous chorioretinopathy. ( 27990593 )
2016
30
En face choroidal vascular feature imaging in acute and chronic central serous chorioretinopathy using swept source optical coherence tomography. ( 27485721 )
2016
31
Shift Work: A Risk Factor for Central Serous Chorioretinopathy. ( 27638449 )
2016
32
Efficacy of photodynamic therapy in steroid-associated chronic central serous chorioretinopathy: a case-control study. ( 27149889 )
2016
33
Circadian disturbance and idiopathic central serous chorioretinopathy. ( 27207466 )
2016
34
CHOROIDAL VASCULARITY INDEX IN CENTRAL SEROUS CHORIORETINOPATHY. ( 27124882 )
2016
35
Recurrent Central Serous Chorioretinopathy Under Combined Vemurafenib and Cobimetinib Treatment. ( 27116515 )
2016
36
Intravitreal Bevacizumab for Treatment of Central Serous Chorioretinopathy. ( 27195087 )
2016
37
Half-dose Photodynamic Therapy for Chronic Central Serous Chorioretinopathy. ( 27195088 )
2016
38
Low-Fluence Photodynamic Therapy versus Subthreshold Micropulse Yellow Wavelength Laser in the Treatment of Chronic Central Serous Chorioretinopathy. ( 27597894 )
2016
39
Findings of Optical Coherence Tomographic Angiography at the Choriocapillaris Level in Central Serous Chorioretinopathy. ( 27606681 )
2016
40
Frequency of Systemic Risk Factors in Central Serous Chorioretinopathy. ( 27539765 )
2016
41
Multimodal Imaging Evaluations of Focal Choroidal Excavations in Eyes with Central Serous Chorioretinopathy. ( 27437148 )
2016
42
Densitometry of Choroidal Vessels in Eyes with and without Central Serous Chorioretinopathy by Wide-Field Indocyanine Green Angiography. ( 27059632 )
2016
43
Preferred practice pattern in central serous chorioretinopathy. ( 27539091 )
2016
44
OPTICAL COHERENCE TOMOGRAPHIC ANGIOGRAPHY IN CENTRAL SEROUS CHORIORETINOPATHY. ( 27164548 )
2016
45
PREVALENCE OF THE COMPLEMENT FACTOR H AND GSTM1 GENES POLYMORPHISMS IN PATIENTS WITH CENTRAL SEROUS CHORIORETINOPATHY. ( 26296146 )
2016
46
MINERALOCORTICOID RECEPTOR ANTAGONIST TREATMENT IN BILATERAL CHRONIC CENTRAL SEROUS CHORIORETINOPATHY: A COMPARATIVE STUDY OF EXUDATIVE AND NONEXUDATIVE FELLOW EYES. ( 27627749 )
2016
47
SHORT-TERM FINDINGS ON OPTICAL COHERENCE TOMOGRAPHY AND MICROPERIMETRY IN CHRONIC CENTRAL SEROUS CHORIORETINOPATHY PATIENTS TREATED WITH HALF-DOSE PHOTODYNAMIC THERAPY. ( 27997459 )
2016
48
Effect of half adult dose of oral Rifampicin (300mg) in patients with idiopathic central serous chorioretinopathy. ( 27882013 )
2016
49
CHANGE OF CHOROIDAL VOLUME IN UNTREATED CENTRAL SEROUS CHORIORETINOPATHY. ( 27941529 )
2016
50
Central serous chorioretinopathy in the fellow eye as a complication of intravitreal dexamethasone implant for the treatment of Irvine-Gass syndrome. ( 27530085 )
2016

Variations for Central Serous Chorioretinopathy

Expression for Central Serous Chorioretinopathy

Search GEO for disease gene expression data for Central Serous Chorioretinopathy.

Pathways for Central Serous Chorioretinopathy

GO Terms for Central Serous Chorioretinopathy

Cellular components related to Central Serous Chorioretinopathy according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 extracellular space GO:0005615 8.92 C4B CFH PLAT SERPINE1

Biological processes related to Central Serous Chorioretinopathy according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 negative regulation of endopeptidase activity GO:0010951 9.26 C4B SERPINE1
2 regulation of complement activation GO:0030449 9.16 C4B CFH
3 complement activation GO:0006956 8.96 C4B CFH
4 fibrinolysis GO:0042730 8.62 PLAT SERPINE1

Sources for Central Serous Chorioretinopathy

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....